Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Taxol | 1 | uM | 5 | 312.50 | 138.75 | 237.00 | 205.75 | 1.1519 | 1.5649 |
| SK-BR-3 | Palbociclib | 3.1623 | uM | 5 | 312.50 | 138.75 | 166.00 | 205.75 | 0.8068 | 0.3709 |
| SK-BR-3 | Omipalisib | 0.0033113 | uM | 5 | 312.50 | 138.75 | 190.00 | 205.75 | 0.9235 | 0.7385 |
| SK-BR-3 | Methotrexate | 0.1 | uM | 5 | 312.50 | 138.75 | 202.00 | 205.75 | 0.9818 | 0.9363 |
| SK-BR-3 | Omipalisib | 10 | uM | 5 | 312.50 | 138.75 | 123.00 | 205.75 | 0.5978 | -0.1910 |
| SK-BR-3 | Methotrexate | 1 | uM | 5 | 312.50 | 138.75 | 275.00 | 205.75 | 1.3366 | 2.3319 |
| SK-BR-3 | Methotrexate | 0.0033113 | uM | 5 | 312.50 | 138.75 | 204.00 | 205.75 | 0.9915 | 0.9702 |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 174.00 | 205.75 | 0.8457 | 0.4893 | |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 161.00 | 205.75 | 0.7825 | 0.2991 | |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 123.00 | 205.75 | 0.5978 | -0.1910 | |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 175.00 | 205.75 | 0.8506 | 0.5043 | |
| SK-BR-3 | Taxol | 0.01 | uM | 5 | 312.50 | 138.75 | 137.00 | 205.75 | 0.6659 | -0.0221 |
| SK-BR-3 | Taxol | 0.1 | uM | 5 | 312.50 | 138.75 | 224.00 | 205.75 | 1.0887 | 1.3225 |
| SK-BR-3 | Methotrexate | 0.31623 | uM | 5 | 312.50 | 138.75 | 282.00 | 205.75 | 1.3706 | 2.4825 |
| SK-BR-3 | Taxol | 0.00016596 | uM | 5 | 312.50 | 138.75 | 197.00 | 205.75 | 0.9575 | 0.8528 |
| SK-BR-3 | Palbociclib | 19.9526 | uM | 5 | 312.50 | 138.75 | 169.00 | 205.75 | 0.8214 | 0.4148 |
| SK-BR-3 | Omipalisib | 0.1 | uM | 5 | 312.50 | 138.75 | 171.00 | 205.75 | 0.8311 | 0.4444 |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 211.00 | 205.75 | 1.0255 | 1.0907 | |
| SK-BR-3 | Palbociclib | 1 | uM | 5 | 312.50 | 138.75 | 153.00 | 205.75 | 0.7436 | 0.1877 |
| SK-BR-3 | Omipalisib | 3.1623 | uM | 5 | 312.50 | 138.75 | 152.00 | 205.75 | 0.7388 | 0.1741 |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 291.00 | 205.75 | 1.4143 | 2.6804 | |
| SK-BR-3 | Omipalisib | 1 | uM | 5 | 312.50 | 138.75 | 159.00 | 205.75 | 0.7728 | 0.2708 |
| SK-BR-3 | Methotrexate | 0.0016596 | uM | 5 | 312.50 | 138.75 | 243.00 | 205.75 | 1.1810 | 1.6802 |
| SK-BR-3 | Palbociclib | 0.01 | uM | 5 | 312.50 | 138.75 | 167.00 | 205.75 | 0.8117 | 0.3855 |
| SK-BR-3 | Taxol | 0.001 | uM | 5 | 312.50 | 138.75 | 147.00 | 205.75 | 0.7145 | 0.1070 |